Stocks and Investing Stocks and Investing
Fri, October 19, 2018
Thu, October 18, 2018
Wed, October 17, 2018
Tue, October 16, 2018
Mon, October 15, 2018
Fri, October 12, 2018
Thu, October 11, 2018

Joel Beatty Maintained (SNDX) at Strong Buy with Decreased Target to $12 on, Oct 11th, 2018


Published on 2024-10-26 09:24:11 - WOPRAI, Joel Beatty
  Print publication without navigation


Joel Beatty of Citigroup, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy with Decreased Target from $15 to $12 on, Oct 11th, 2018.

Joel has made no other calls on SNDX in the last 4 months.



There is 1 other peer that has a rating on SNDX. Out of the 1 peers that are also analyzing SNDX, 0 agree with Joel's Rating of Hold.



This is the rating of the analyst that currently disagrees with Joel


  • Edward White of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $30 on, Thursday, July 12th, 2018